In the event of a breach of the applicable legislative or regulatory provisions or of the requirements laid down in the authorisation, the Director General of the Agence de la biomédecine may give the establishment or body formal notice to put an end to the breaches observed and, where appropriate, to submit its observations within a period set by the Director General.
If the measures taken are not such as to put an end to these breaches, the Director General of the Agency may notify the establishment or body of his decision:
1° to suspend the authorisation for a maximum period of three months, specifying the requirements with which the organisation must comply in order to recover the benefit of the authorisation;
2° to withdraw the authorisation.
The decision of the Director General of the Agency may be accompanied by requirements relating to the future of the embryos. It may arrange for them to be transferred to another establishment or organisation, which the Director General shall designate if necessary.
In an emergency, the Director General may use his power of suspension without prior formal notice.
The decisions referred to in 1° and 2° above are taken after obtaining the public opinion of the Agency’s Policy Board.